Literature DB >> 33594422

Demonstrating the sustainability of capacity strengthening amidst COVID-19.

P Abomo1, E M Miaka2, S J Crossman3, A Hope4.   

Abstract

The global disruptions caused by the coronavirus disease 2019 crisis posed a threat to the momentum the vector control team at the Liverpool School of Tropical Medicine (LSTM) and the Programme National de Lutte contre la Tryaponosomiase Humaine Africaine (PNLTHA) had built in their efforts to control tsetse fly populations in the Democratic Republic of Congo. But despite the pandemic and global lockdown, field activities did continue and the same impressive results in tsetse fly reduction were observed and the team followed this by completing a round of 'tiny target' deployment without any external presence. Such a success was possible due to the investment in vector control capacity strengthening undertaken by the LSTM and PNLTHA.
© The Author(s) 2021. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  COVID-19; DRC; Gambian human African trypanosomiasis; capacity strengthening; lockdown; tiny targets

Year:  2021        PMID: 33594422     DOI: 10.1093/inthealth/ihab004

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  2 in total

1.  Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study.

Authors:  Anna Borlase; Epke A Le Rutte; Soledad Castaño; David J Blok; Jaspreet Toor; Federica Giardina; Emma L Davis
Journal:  Lancet Glob Health       Date:  2022-11       Impact factor: 38.927

2.  Update of transmission modelling and projections of gambiense human African trypanosomiasis in the Mandoul focus, Chad.

Authors:  Kat S Rock; Ching-I Huang; Ronald E Crump; Paul R Bessell; Paul E Brown; Inaki Tirados; Philippe Solano; Marina Antillon; Albert Picado; Severin Mbainda; Justin Darnas; Emily H Crowley; Steve J Torr; Mallaye Peka
Journal:  Infect Dis Poverty       Date:  2022-01-24       Impact factor: 4.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.